PanOptica is a biopharmaceutical company developing a topical eye drop for the treatment of eye diseases caused by abnormal or leaky blood vessels.
Employees: 51-200
Total raised: $86M
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | SV Health ... | svhealthin... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 06.10.2017 | Series B | $11M | - |
| 15.04.2014 | Series B | $45M | - |
| 04.01.2011 | Series A | $30M | - |
Mentions in press and media 5
| Date | Title | Description |
| 10.10.2017 | Term Sheet — Tuesday, October 10 | BIG MONEY, FEW DEALS Good morning, Term Sheet readers. Paid Content How can you protect what you can't see? From ExtraHop But here’s the twist. Investors are pumping larger amounts of capital into fewer companies. In other words, a small pe... |
| 09.10.2017 | PanOptica Secures $11M in Series B | BERNARDSVILLE, NJ, Private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that it has secured $11 million in a Series B financing. >> Click here for more funding data on PanOptic... |
| 06.10.2017 | PanOptica Secures $11M in Series B Financing | PanOptica, Inc., a Bernardsville, NJ-based private biopharmaceutical company focused on developing innovative ophthalmology therapies, secured $11m in Series B financing. Backers included Third Rock Ventures and SV Health Investors (formerl... |
| 15.04.2014 | PanOptica Closes Up To $45M in Series B Funding | PanOptica, a Bernardsville, NJ-based biopharmaceutical company focused on ophthalmology therapies, closed up to $45m in Series B funding. The round was led by Novo Ventures and Third Rock Ventures with participation from SV Life Sciences. T... |
| 04.01.2011 | PanOptica Raises $30m in Series A Financing | PanOptica, Inc., a Mount Arlington, New Jersey-based biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies, has raised $30m in a Series A financing. The round was led by SV Life Sciences and Third ... |